Your search returned 8 results.

Results
	1.	The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany. [electronic resource] by Dintsios, C M Beinhauer, I Publication details: Health economics review Mar 2020 In: Health economics review vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	[Health-Related Quality of Life in the Context of Early Benefit Assessment of Drugs According to § 35a of the German Social Code Book V: A Challenging Endpoint for all the Involved Stakeholders]. [electronic resource] by Bender, H Dintsios, C-M Producer: 20190617 In: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	When suddenly the evaluation became a validation. [electronic resource] by Dintsios, C M Niederstadt, C Producer: 20160420 In: Journal of clinical epidemiology vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree. [electronic resource] by Dintsios, C M Worm, F Ruof, J Herpers, M Publication details: Health economics review Dec 2019 In: Health economics review vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	[Patient-reported and patient-weighted outcomes in ophthalmology]. [electronic resource] by Scheibler, F Finger, R P Grosselfinger, R Dintsios, C-M Producer: 20100830 In: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	[IQWiG's methods for the cost-benefit assessment : Comparison with an international reference scenario]. [electronic resource] by Schwalm, A Danner, M Seidl, A Volz, F Dintsios, C M Gerber, A Producer: 20101123 In: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study. [electronic resource] by Bächle, C Claessen, H Andrich, S Brüne, M Dintsios, C M Slomiany, U Roggenbuck, U Jöckel, K H Moebus, S Icks, A Producer: 20160602 In: BMJ open diabetes research & care vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	[Methods of health economic evaluation for health services research]. [electronic resource] by Icks, A Chernyak, N Bestehorn, K Brüggenjürgen, B Bruns, J Damm, O Dintsios, C-M Dreinhöfer, K Gandjour, A Gerber, A Greiner, W Hermanek, P Hessel, F Heymann, R Huppertz, E Jacke, C Kächele, H Kilian, R Klingenberger, D Kolominsky-Rabas, P Krämer, H Krauth, C Lüngen, M Neumann, T Porzsolt, F Prenzler, A Pueschner, F Riedel, R Rüther, A Salize, H J Scharnetzky, E Schwerd, W Selbmann, H-K Siebert, H Stengel, D Stock, S Völler, H Wasem, J Schrappe, M Producer: 20110418 In: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)